Vivanza Biosciences Stock Screener | Share Price & Fundamental Analysis
VIVANZA
Pharmaceuticals
Share Price BSE
₹1.96
▼
-0.08 (-3.92%)
Track Vivanza Biosciences share price live with TickJournal's free stock screener.
Analyze Vivanza Biosciences share price history trends and compare 52-week high low
levels.
Calculate VIVANZA stock fair value using fundamental analysis and view live share price charts.
Determine Vivanza Biosciences share intrinsic value and compare it with current VIVANZA share price.
Record your Vivanza Biosciences trades in TickJournal's free trading journal and track your portfolio performance.
Vivanza Biosciences Market Cap
₹8.20 Cr.
VIVANZA P/E Ratio (TTM)
15.00
EPS (TTM)
₹-0.17
Dividend Yield
-
Debt to Equity
1.61
VIVANZA 52 Week High
₹2.84
Vivanza Biosciences 52 Week Low
₹1.96
Operating Margin
-200.00%
Profit Margin
-100.00%
VIVANZA Revenue (TTM)
₹1.00
EBITDA
₹-1.00
Net Income
₹-1.00
Total Assets
₹17.00
Total Equity
₹4.00
Vivanza Biosciences Share Price History - Stock Screener Chart
Screen VIVANZA historical share price movements with interactive charts. Analyze price trends and patterns.
Vivanza Biosciences Company Profile - Fundamental Screener
Screen Vivanza Biosciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VIVANZA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE984E01035
Vivanza Biosciences Balance Sheet Screener
Screen VIVANZA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 17 | 20 | 23 | 16 | 8 | 12 | 11 | 10 | 7 | 1 |
| Current Assets | 12 | 16 | 20 | 13 | 5 | 9 | 8 | 7 | 4 | 0 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 17 | 20 | 23 | 16 | 8 | 12 | 11 | 10 | 7 | 1 |
| Current Liabilities | 3 | 3 | 1 | 3 | 0 | 0 | 1 | 1 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 4 | 5 | 4 | 4 | 3 | 3 | 3 | 4 | 4 | 0 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 0 |
| Reserves & Surplus | 0 | 1 | 0 | -1 | -1 | -1 | -1 | 0 | -1 | 0 |
Vivanza Biosciences Income Statement Screener - Profit & Revenue Analysis
Screen Vivanza Biosciences income statement and profit fundamentals.
Analyze VIVANZA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vivanza Biosciences share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 9 | 55 | 4 | 2 | 3 | 2 | 8 | 9 | 8 | 7 | 6 | 2 | 2 | 6 |
| Expenses | 1 | 9 | 55 | 5 | 2 | 3 | 1 | 8 | 9 | 7 | 6 | 6 | 2 | 1 | 5 |
| EBITDA | -1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Operating Profit % | -200.00% | 2.00% | 1.00% | -3.00% | 15.00% | 4.00% | 8.00% | 0.00% | 6.00% | 4.00% | 4.00% | -7.00% | 6.00% | -2.00% | 10.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| EPS | -0.25 | 0.02 | 0.14 | -0.10 | 0.07 | 0.00 | 0.01 | -0.26 | 0.12 | 0.07 | 0.05 | -0.50 | 0.19 | 0.42 | 1.15 |
Vivanza Biosciences Cash Flow Screener - Liquidity Fundamentals
Screen VIVANZA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -3 | 2 | -1 | 3 | -3 | 3 | 1 | 0 | -2 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
| Financing Activities | 3 | -2 | 1 | -3 | 3 | -3 | -1 | -1 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
Vivanza Biosciences Shareholding Pattern Screener
See Vivanza Biosciences shareholding pattern with promoter, FII, and DII holdings.
Check Vivanza Biosciences promoter holding and ownership changes for VIVANZA on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 20.02% | 20.02% | 20.02% | 43.24% | 40.05% | 39.86% | 20.02% | 47.80% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 73.69% | 73.36% | 73.34% | 13.82% | 45.01% | 51.05% | 71.21% | 5.65% |
| Other Holding | 6.29% | 6.62% | 6.64% | 42.94% | 14.94% | 9.09% | 8.77% | 46.55% |
| Shareholder Count | 20,833 | 20,458 | 20,170 | 6,992 | 16,941 | 16,701 | 20,635 | 4,865 |
Vivanza Biosciences Share Dividend Screener - Share Yield Analysis
Check Vivanza Biosciences dividend history with payout and yield data.
View Vivanza Biosciences dividend details including ex-dates and amounts for VIVANZA stock.
Vivanza Biosciences Stock Index Membership
See which indices include Vivanza Biosciences stock.
Check VIVANZA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Vivanza Biosciences Market Events Screener - Corporate Actions
Get Vivanza Biosciences corporate actions including splits, bonuses, and buybacks.
Check Vivanza Biosciences stock events that may affect VIVANZA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -0.48% | ||
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 0.51% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 2.45% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -4.59% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -2.93% |
| 2024-10-17 | 2024-10-17 | Quarterly Result Announcement | NA | -6.39% |
| 2024-08-01 | 2024-08-01 | Annual General Meeting | NA | -4.19% |
| 2023-03-24 | 2023-01-24 | Split | 1:10 | 0.00% |
| 2022-07-21 | 2022-07-21 | Annual General Meeting | NA | 3.17% |
| 2016-02-17 | 2016-02-17 | Change Of Name | NA | - |
Vivanza Biosciences Competitors Screener - Peer Comparison
Screen VIVANZA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,682 | 40.53 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 173,019 | 69.57 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 128,829 | 60.33 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,601 | 22.48 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,198 | 18.68 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 96,937 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,780 | 18.37 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 92,070 | 50.91 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,346 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,494 | 27.88 | 13,458 | 3.70% | 2,216 | 49.80 |
Vivanza Biosciences Company Announcements - News Screener
Screen VIVANZA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-27 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2026-02-26 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2026-02-26 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2026-02-21 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-04 | Reg. 34 (1) Annual Report. | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-11-14 | Results - Financial Results For 30Th September 2025 | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-11 | Non-Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations 2015 For The Quarter And Half Year Ended On 30Th September 2025 | View |
| 2025-11-11 | Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-11 | Postal Ballot For Alteration Of The Main Object Clause Of The Memorandum Of Association Of The Company | View |
| 2025-11-11 | Financial Results For The Quarter Ended 30Th September 2025 | View |
| 2025-11-11 | Board Meeting Outcome for The Board Meeting Held On 11Th November 2025 | View |
| 2025-11-03 | Board Meeting Intimation for Notice For The Meeting Of The Board Of Directors Pursuant To Regulation 29 And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-06 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-10-05 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |